Related references
Note: Only part of the references are listed.Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma
Lilla Krokker et al.
NEUROCHEMICAL RESEARCH (2019)
Correlation between immunohistochemistry and RICTOR fluorescence in situ hybridization amplification in small cell lung carcinoma
Ildiko Krencz et al.
HUMAN PATHOLOGY (2019)
Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain
Sravani Polepalli et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine
Mika Hosokawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Grzegorz Helbig et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
DNA Hydroxymethylation Levels Are Altered in Blood Cells From Down Syndrome Persons Enrolled in the MARK-AGE Project
Fabio Ciccarone et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes
Matthew P. Salomon et al.
CLINICAL CANCER RESEARCH (2018)
In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease
Marta Starczak et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
DNA methylation profiling in nonfunctioning pituitary adenomas
Paulina Kober et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas
Hou-Shi Ma et al.
MEDICAL SCIENCE MONITOR (2018)
Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study
Alin Grelus et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics
Harsimran Sidhu et al.
TUMOR BIOLOGY (2017)
Single-molecule quantification of 5-hydroxymethylcytosine for diagnosis of blood and colon cancers
Noa Gilat et al.
CLINICAL EPIGENETICS (2017)
TET family dioxygenases and DNA demethylation in stem cells and cancers
Jungeun An et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer
Ke Chen et al.
CELL RESEARCH (2016)
Human blood cell levels of 5-hydroxymethylcytosine (5hmC) decline with age, partly related to acquired mutations in TET2
Manuel Buscarlet et al.
EXPERIMENTAL HEMATOLOGY (2016)
Targeting the cancer epigenome for therapy
Peter A. Jones et al.
NATURE REVIEWS GENETICS (2016)
Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity
Huarui Lu et al.
ONCOTARGET (2016)
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Lucas B. Sullivan et al.
NATURE REVIEWS CANCER (2016)
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine
Michelle L. Stewart et al.
CANCER RESEARCH (2015)
The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells
Basudev Chowdhury et al.
SCIENTIFIC REPORTS (2015)
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
Michael Christoph Haffner et al.
Oncotarget (2015)
The role of 5-hydroxymethylcytosine in human cancer
Gerd P. Pfeifer et al.
CELL AND TISSUE RESEARCH (2014)
TET-catalyzed 5-methylcytosine hydroxylation is dynamically regulated by metabolites
Hui Yang et al.
CELL RESEARCH (2014)
Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas
Jie Feng et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Structural Basis for Hydroxymethylcytosine Recognition by the SRA Domain of UHRF2
Ting Zhou et al.
MOLECULAR CELL (2014)
5-Hydroxymethylcytosine is a predominantly stable DNA modification
Martin Bachman et al.
NATURE CHEMISTRY (2014)
A Pilot Genome-Scale Profiling of DNA Methylation in Sporadic Pituitary Macroadenomas: Association with Tumor Invasion and Histopathological Subtype
Chao Ling et al.
PLOS ONE (2014)
The Nuclear Protein UHRF2 Is a Direct Target of the Transcription Factor E2F1 in the Induction of Apoptosis
Huarui Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TET enzymes, TDG and the dynamics of DNA demethylation
Rahul M. Kohli et al.
NATURE (2013)
Charting a dynamic DNA methylation landscape of the human genome
Michael J. Ziller et al.
NATURE (2013)
Concise Drug Review: Azacitidine and Decitabine
Ellen J. B. Derissen et al.
ONCOLOGIST (2013)
Tet family proteins and 5-hydroxymethylcytosine in development and disease
Li Tan et al.
DEVELOPMENT (2012)
Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas
Cuong V Duong et al.
ENDOCRINE-RELATED CANCER (2012)
Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes
Colm E. Nestor et al.
GENOME RESEARCH (2012)
UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis
Jaime Chu et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
The pituitary tumour epigenome: aberrations and prospects for targeted therapy
Kiren Yacqub-Usman et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers
Ekaterina Olkhov-Mitsel et al.
CANCER MEDICINE (2012)
Simultaneous Determination of Global DNA Methylation and Hydroxymethylation Levels by Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry
Liangtao Zhang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development
Alexey Ruzov et al.
CELL RESEARCH (2011)
Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis
Haneen Al-Azzawi et al.
ENDOCRINOLOGY (2011)
Identification of Growth Arrest and DNA-Damage-Inducible Gene β (GADD45β) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors
Katherine A. Michaelis et al.
ENDOCRINOLOGY (2011)
Chromatin landscape Methylation beyond transcription
Joshua C. Black et al.
EPIGENETICS (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito et al.
SCIENCE (2011)
Distribution of 5- Hydroxymethylcytosine in Different Human Tissues
Weiwei Li et al.
JOURNAL OF NUCLEIC ACIDS (2011)
Identification of methylation-associated gene expression in neuroendocrine pancreatic tumor cells
Nils Habbe et al.
PANCREATOLOGY (2007)
Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry
LG Song et al.
ANALYTICAL CHEMISTRY (2005)
Denaturing RNA electrophoresis in TAE agarose gels
T Masek et al.
ANALYTICAL BIOCHEMISTRY (2005)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
